20 related articles for article (PubMed ID: 38512035)
1. Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation.
Zhou K; Wu C; Cheng W; Zhang B; Wei R; Cheng D; Li Y; Cao Y; Zhang W; Yao Z; Zhang X
Cell Death Dis; 2024 Apr; 15(4):252. PubMed ID: 38589352
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma.
Chen S; Chen H; Wang X; Zhang D; Zhang L; Cheng J; Zhang Q; Hua Z; Miao X; Shi J
An Bras Dermatol; 2024; 99(4):535-545. PubMed ID: 38548549
[TBL] [Abstract][Full Text] [Related]
3. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
Tao SN; Liu XC; Wang YY; Yang H
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
[No Abstract] [Full Text] [Related]
4. NR5A2 promotes malignancy progression and mediates the effect of cisplatin in cutaneous squamous cell carcinoma.
Ye W; Ya-Xuan C; Shan-Shan T; Qiu L; Ting M; Shao-Jie C; Yu C
Immun Inflamm Dis; 2024 Feb; 12(2):e1172. PubMed ID: 38358044
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-451a prevents cutaneous squamous cell carcinoma progression via the 3-phosphoinositide-dependent protein kinase-1-mediated PI3K/AKT signaling pathway.
Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
Exp Ther Med; 2021 Feb; 21(2):116. PubMed ID: 33335579
[TBL] [Abstract][Full Text] [Related]
6. SPAG5 promotes the proliferation, migration, invasion, and epithelial-mesenchymal transformation of colorectal cancer cells by activating the PI3K/AKT signaling pathway.
Zhang X; Wu W; Li X; He F; Zhang L
Chin J Physiol; 2023; 66(5):365-371. PubMed ID: 37929348
[TBL] [Abstract][Full Text] [Related]
7. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.
Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y
J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041
[TBL] [Abstract][Full Text] [Related]
8. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
Lu D; Sun L; Li Z; Mu Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR.
Mei XL; Zhong S
Chin Med J (Engl); 2019 Feb; 132(4):454-465. PubMed ID: 30707166
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway.
Ci C; Wu C; Lyu D; Chang X; He C; Liu W; Chen L; Ding W
Clin Exp Dermatol; 2020 Mar; 45(2):194-201. PubMed ID: 31419330
[TBL] [Abstract][Full Text] [Related]
11. [Role of long noncoding RNA MALAT1 promotes the occurrence and progression of cutaneous squamous cell carcinoma].
Li SS; Zhou L; Gao L; Wang YH; Ding ZH
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):421-427. PubMed ID: 29735442
[TBL] [Abstract][Full Text] [Related]
12. [Yes-associated protein (YAP) promotes invasion and migration of cutaneous squamous cell carcinoma cells by activating the PI3K/AKT pathway].
Li Z; Yang F; Jin X; Wang X; Chen T; Quan C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):244-251. PubMed ID: 38512035
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
